Literature DB >> 10904098

MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ.

F R Miller, S J Santner, L Tait, P J Dawson.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10904098     DOI： 10.1093/jnci/92.14.1185a

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  179 in total

1.  Modeling stromal-epithelial interactions in disease progression.

Authors:  Douglas W Strand; Simon W Hayward
Journal:  Discov Med       Date:  2010-06       Impact factor: 2.970

2.  The RasGAP gene, RASAL2, is a tumor and metastasis suppressor.

Authors:  Sara Koenig McLaughlin; Sarah Naomi Olsen; Benjamin Dake; Thomas De Raedt; Elgene Lim; Roderick Terry Bronson; Rameen Beroukhim; Kornelia Polyak; Myles Brown; Charlotte Kuperwasser; Karen Cichowski
Journal:  Cancer Cell       Date:  2013-09-09       Impact factor: 31.743

3.  Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFβ signaling.

Authors:  Pang-Kuo Lo; Yongshu Zhang; Yuan Yao; Benjamin Wolfson; Justine Yu; Shu-Yan Han; Nadire Duru; Qun Zhou
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

4.  Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.

Authors:  Pratima Nangia-Makker; Tirza Raz; Larry Tait; Malathy P V Shekhar; Hong Li; Vitaly Balan; Hemanckur Makker; Rafael Fridman; Krishnarao Maddipati; Avraham Raz
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

5.  Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.

Authors:  Elizabeth J Pereira; Joseph S Burns; Christina Y Lee; Taylor Marohl; Delia Calderon; Lixin Wang; Kristen A Atkins; Chun-Chao Wang; Kevin A Janes
Journal:  Sci Signal       Date:  2020-04-14       Impact factor: 8.192

6.  Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.

Authors:  Alexandra C Silveira; Douglas R Hurst; Kedar S Vaidya; Donald E Ayer; Danny R Welch
Journal:  Cancer Lett       Date:  2008-12-13       Impact factor: 8.679

7.  Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.

Authors:  Malathy P V Shekhar; Pratima Nangia-Makker; Larry Tait; Fred Miller; Avraham Raz
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Differential Expression of Key Signaling Proteins in MCF10 Cell Lines, a Human Breast Cancer Progression Model.

Authors:  Jae Young So; Hong Jin Lee; Pavel Kramata; Audrey Minden; Nanjoo Suh
Journal:  Mol Cell Pharmacol       Date:  2012-01-01

9.  Regulation of in situ to invasive breast carcinoma transition.

Authors:  Min Hu; Jun Yao; Danielle K Carroll; Stanislawa Weremowicz; Haiyan Chen; Daniel Carrasco; Andrea Richardson; Shelia Violette; Tatiana Nikolskaya; Yuri Nikolsky; Erica L Bauerlein; William C Hahn; Rebecca S Gelman; Craig Allred; Mina J Bissell; Stuart Schnitt; Kornelia Polyak
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

10.  Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.

Authors:  Brandon J Metge; Andra R Frost; Judy A King; Donna Lynn Dyess; Danny R Welch; Rajeev S Samant; Lalita A Shevde
Journal:  Clin Exp Metastasis       Date:  2008-06-20       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.